Seeking Alpha
All posts from Seeking Alpha
Seeking Alpha in Seeking Alpha - Read, Decide, Invest.,

InVivo Therapeutics: Long Idea Playing Out With Room To Run

InVivo Therapeutics Holdings Corp. (OTCQB:NVIV) has been on a tear since it announced the treatment of its first spinal cord injury patient on October 15th of last year. A month prior, I identified InVivo in a Seeking Alpha article as the perfect situational investment. Since that time, the stock price had appreciated by 342% before settling back down to $2 a share (300% gain) after announcing a $12 million capital raise. We think InVivo has room to run and is only in the second inning of what will prove to be a blow out game over the next few years. Here's…